HOME >> BIOLOGY >> NEWS
Umbilical cord blood transplants, bone marrow transplants save lives

MAYWOOD, Ill. Umbilical cord blood and bone marrow transplants at Loyola University are curing or slowing the progression of many cancers originating in the bone marrow (i.e., leukemia, myeloma) or lymphatic system (lymphoma).

More than 106,000 people in the U.S. each year are diagnosed with these life-threatening diseases.

"Even if other treatments have produced no results, a bone marrow transplant may save the patient's life," said Dr. Patrick J. Stiff, director of the Cardinal Bernardin Cancer Center and the Bone Marrow Transplant Program at Loyola University Medical Center, Maywood, Ill. Patients unable to find a matching bone marrow donor may have an alternative with umbilical cord blood (CB) transplantation.

Loyola's unique method of preparing the umbilical cord blood enables more stem cells to survive, according to Stiff, who also is professor of Medicine and Pathology, Loyola University Chicago Stritch School of Medicine.

A transplant provides the patient with healthy, new stem cells to develop a new immune system. And it's working.

Holly Drucker, 30, of Chicago's north side; Adam McGillen, 25, of Sandwich, Ill.; Moira Minielly, 39, of Wilmette, Ill.; and Donna Marasco, 45, of Bolingbrook, Ill., were dying of cancer when they arrived at Loyola's Cardinal Bernadin Cancer Center during the past six years. At Loyola, Holly and Adam underwent umbilical cord blood transplant for non-Hodgkin's lymphoma. Moira, diagnosed with non-Hodgkin's lymphoma, and Donna, with chronic myelogenous leukemia, underwent bone marrow transplant at Loyola. Today all four are leading productive, happy lives.

Loyola has the largest bone marrow transplantation program in the Midwest, performing 160 transplants each year. It is a participating center in the National Marrow Donor Program network.

The latest statistics from the National Marrow Donor Program Network show the actual one-year patient su
'"/>

Contact: Joanne Swanson
jswanson@lumc.edu
708-216-2445
Loyola University Health System
1-Jun-2004


Page: 1 2 3

Related biology news :

1. Umbilical cord matrix, a rich new stem cell source, study shows
2. Duke Study Shows Umbilical Cord Blood Transplant Is Viable Treatment For Genetic Disorders
3. Experimental drug shown to block mutant protein causing blood disease
4. IBD (Crohns, Colitis) joins cancer, inflammatory diseases in associated blood vessel growth
5. A probable cause for high blood pressure identified - shows links with diabetes
6. Probing the surface of white blood cells to enhance immune system medicine
7. Streptococcus infects humans by thwarting blood clotting
8. Strep disrupts blood clotting to infect humans
9. Nucleic acid-amplification testing further safeguards nations blood supply
10. Hopkins scientists use blood proteins to detect ovarian cancer
11. Marijuana ingredient inhibits VEGF pathway required for brain tumor blood vessels

Post Your Comments:
(Date:3/17/2015)... , March 17, 2015 ... company specializing in clinical study management systems, is ... in attendance at ARENA,s Outsourcing in Clinical Trials ... This event provides an excellent forum for MedNet ... flexible and affordable software-as-a-service (SaaS) eClinical technology platform. ...
(Date:3/12/2015)... Va. , March 12, 2015 IriTech, ... and a member of the Texas Instruments Design Network, ... Naidu has demonstrated its IriShield USB MK2120U device ... scanning facility for pension distribution. The ... assembled to be marketed in India ...
(Date:3/11/2015)... Research and Markets ( http://www.researchandmarkets.com/research/3p32qm/access_control ) ... Market by Product, Application & By Geography - Global ... offering. , This report predicts that the ... by 2020, with an estimated CAGR of 10.6%. ... types such as contact cards & readers, contactless cards ...
Breaking Biology News(10 mins):Connect With MedNet Solutions At Outsourcing In Clinical Trials Southeast 2Indian States See IriTech's Scanner Bolstering Efficiency of Authentication for Aadhaar 2Indian States See IriTech's Scanner Bolstering Efficiency of Authentication for Aadhaar 3Global Access Control (Cards & Readers, Biometrics, Controllers, Management Software) Market 2015-2020 - Analysis of the $10 Billion Market 2
(Date:3/29/2015)... Texas , March 29, 2015 /PRNewswire/ ... presentation of important study data showing the ... in 1,599 gynecologic cancer samples. Using Caris ... profiling service, researchers identified expression of programmed ... cancers independent of histology while its ligand ...
(Date:3/27/2015)... 2015  Neogen Corporation (NASDAQ: NEOG ) announced ... trading plan in accordance with Securities and Exchange Commission ... of Neogen Corporation, is a minority owner of this ... Herbert does not have control of this ... is only for a portion of the shares owned ...
(Date:3/27/2015)... ROCKVILLE, Md. , March 27, 2015  CASI ... dedicated to the acquisition, development and commercialization of innovative ... the global market with a commercial focus on ... the three and 12 months ended December 31, 2014.  ... of ($1.6 million), or ($0.05) per share, for the ...
(Date:3/26/2015)... The Market Element LLC, a leading inbound ... Designing Gig LLC to provide website design, development, and ... this alliance with Designing Gig represents a pivotal moment ... comprehensive, end-to-end, digital solution for our clients, which now ... Miller, president of The Market Element. “For small and ...
Breaking Biology Technology:Caris Life Sciences' Multiplatform Tumor Profiling Technology Identifies Expression of PD-1 and PD-L1 in Gynecologic Malignancies 2Caris Life Sciences' Multiplatform Tumor Profiling Technology Identifies Expression of PD-1 and PD-L1 in Gynecologic Malignancies 3Caris Life Sciences' Multiplatform Tumor Profiling Technology Identifies Expression of PD-1 and PD-L1 in Gynecologic Malignancies 4Neogen CEO adopts 10b5-1 Trading Plan 2CASI Pharmaceuticals Reports 2014 Fourth Quarter And Full Year Financial Results 2CASI Pharmaceuticals Reports 2014 Fourth Quarter And Full Year Financial Results 3CASI Pharmaceuticals Reports 2014 Fourth Quarter And Full Year Financial Results 4CASI Pharmaceuticals Reports 2014 Fourth Quarter And Full Year Financial Results 5CASI Pharmaceuticals Reports 2014 Fourth Quarter And Full Year Financial Results 6The Market Element LLC and Designing Gig LLC Form Strategic Alliance 2
Cached News: